Hepatocellular Carcinoma Clinical Trials in Wuhan, Hubei
16 recruitingWuhan, Hubei, China
Showing 1–16 of 16 trials
Recruiting
Phase 1
A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
Metastatic Hepatocellular CarcinomaLocal Advanced Hepatocellular CarcinomaAlpha-fetoprotein (AFP)-Producing Gastric Cancer+2 more
BeOne Medicines140 enrolled19 locationsNCT06427941
Recruiting
Phase 2
Tislelizumab Combined With Huaier Granule as First-line Treatment for Unresectable Hepatocellular Carcinoma
Hepatocellular Carcinoma (HCC)
Tongji Hospital94 enrolled1 locationNCT07413354
Recruiting
Phase 2
ABSK-011+BSC vs. Placebo+BSC in Previously Treated Advanced HCC With FGF19 Overexpression
Hepatocellular Carcinoma (HCC)
Abbisko Therapeutics Co, Ltd141 enrolled51 locationsNCT07327034
Recruiting
Deep Learning-Based Multidimensional Body Composition Mapping for Outcome Prediction in HCC Patients Undergoing TACE
Hepatocellular Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology300 enrolled1 locationNCT07235410
Recruiting
Phase 2
Apatinib Mesylate and Camrelizumab Combined With TACE as Neoadjuvant Therapy for Hepatocellular Carcinoma
Hepatocellular Carcinoma (HCC)
Wei Zhang27 enrolled1 locationNCT07154082
Recruiting
Impact of Splenectomy on the Efficacy of Targeted Therapy and Immunotherapy in Unresectable HCC Patients With Cirrhotic Portal Hypertension
Unresectable Hepatocellular Carcinoma
Zhiyong Huang60 enrolled1 locationNCT06280313
Recruiting
Predicting Immunotherapy Response and Survival of Liver Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Liver)
Hepatocellular Carcinoma (HCC)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology350 enrolled1 locationNCT07059936
Recruiting
Phase 3
Chinese HCC Efficacy Evaluation, Response and Safety Study of TareSphere
Unresectable Hepatocellular Carcinoma
Chengdu New Radiomedicine Technology Co. LTD.108 enrolled11 locationsNCT06900543
Recruiting
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma
Hepatocellular Carcinoma Non-resectable
Ze-yang Ding, MD300 enrolled2 locationsNCT05713994
Recruiting
Phase 1
A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves Through the Bodies of Adult Chinese Participants With Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC)
Hepatocellular Carcinoma (HCC)
AbbVie20 enrolled11 locationsNCT06487559
Recruiting
Ambispective Cohort Study of Precision Medicine for Primary Hepatobiliary Cancer Based on Next-generation Sequencing
Biliary Tract CancerHepatocellular Carcinoma
Tongji Hospital200 enrolled1 locationNCT05520788
Recruiting
Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Hepatocellular Carcinoma Recurrence Surveillance
Hepatocellular Carcinoma (HCC)
Tongji Hospital50 enrolled1 locationNCT06653062
Recruiting
Phase 2
Combined HAIC, Lenvatinib and Cadonilimab As Conversion Therapy for Unresectable Hepatocellular Carcinoma
Hepatocellular Carcinoma Non-resectable
Tongji Hospital36 enrolled1 locationNCT06187961
Recruiting
Phase 1
Palliative Hepatectomy Combined With Targeted Therapy and Immunotherapy for Advanced Hepatocellular Carcinoma
Advanced Hepatocellular Carcinoma
Zhiyong Huang50 enrolled1 locationNCT06470256
Recruiting
Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular Carcinoma
Hepatocellular Carcinoma Non-resectable
Tongji Hospital300 enrolled4 locationsNCT05717738
Recruiting
Phase 2
HAIC (Hepatic Artery Infusion Chemotherapy，HAIC）Plus Sintilimab and Donafenib in the First-line Treatment of Unresectable Hepatocellular Carcinoma
Hepatocellular Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology38 enrolled1 locationNCT06244225